We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+5.33%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
AUM
$3.31B
AUM Growth
+$137M
Cap. Flow
-$19.3M
Cap. Flow %
-0.58%
Top 10 Hldgs %
19.11%
Holding
681
New
89
Increased
221
Reduced
279
Closed
84

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$34.1M
2
AMGN icon
Amgen
AMGN
+$28.6M
3
GE icon
GE Aerospace
GE
+$26.9M
4
WBA
Walgreens Boots Alliance
WBA
+$16.4M
5
EMC
EMC CORPORATION
EMC
+$14.4M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$29.7M
2
AGN
Allergan Inc
AGN
+$22.5M
3
JPM icon
JPMorgan Chase
JPM
+$18M
4
C icon
Citigroup
C
+$17.2M
5
COST icon
Costco
COST
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 16.56%
2 Financials 15.71%
3 Technology 13.48%
4 Energy 10.9%
5 Consumer Staples 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$100M 3.04%
4,322,016
-301,400
-7% -$6.41M
XOM icon
2
ExxonMobil
XOM
$644B
$73M 2.21%
725,557
-11,050
-2% -$1.11M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.19T
$73M 2.21%
2,524,853
+10,423
+0.4% +$283K
MSFT icon
4
Microsoft
MSFT
$3.81T
$62.6M 1.89%
1,500,175
+36,150
+2% +$1.46M
PG icon
5
Procter & Gamble
PG
$334B
$60.7M 1.84%
772,520
+15,170
+2% +$1.22M
GE icon
6
GE Aerospace
GE
$355B
$60.3M 1.82%
478,506
+211,326
+79% +$26.9M
PEP icon
7
PepsiCo
PEP
$193B
$54.1M 1.64%
605,355
+47,118
+8% +$4.07M
CVX icon
8
Chevron
CVX
$396B
$51.4M 1.55%
393,386
+1,000
+0.3% +$124K
JNJ icon
9
Johnson & Johnson
JNJ
$646B
$49.5M 1.5%
473,541
-105,050
-18% -$10.6M
WFC icon
10
Wells Fargo
WFC
$262B
$47M 1.42%
893,781
+35,543
+4% +$1.79M
SLB icon
11
SLB Ltd
SLB
$85.1B
$44.5M 1.35%
377,518
-710
-0.2% -$73.2K
AXP icon
12
American Express
AXP
$225B
$44.1M 1.33%
464,430
+71,970
+18% +$6.49M
AMGN icon
13
Amgen
AMGN
$234B
$43.4M 1.31%
366,413
+247,146
+207% +$28.6M
VZ icon
14
Verizon
VZ
$208B
$43.3M 1.31%
885,057
+703,800
+388% +$34.1M
PFE icon
15
Pfizer
PFE
$159B
$43M 1.3%
1,527,528
+53,821
+4% +$1.53M
JPM icon
16
JPMorgan Chase
JPM
$951B
$41.3M 1.25%
716,377
-319,801
-31% -$18M
MRK icon
17
Merck
MRK
$366B
$39.3M 1.19%
711,928
+628
+0.1% +$34.3K
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.08T
$38.6M 1.17%
304,689
-800
-0.3% -$101K
NKE icon
19
Nike
NKE
$58.7B
$33.4M 1.01%
860,160
-86,980
-9% -$3.24M
DIS icon
20
Walt Disney
DIS
$187B
$33.3M 1.01%
388,642
-7,855
-2% -$642K
CSCO icon
21
Cisco
CSCO
$433B
$32.8M 0.99%
1,318,256
-79,500
-6% -$1.89M
BAC icon
22
Bank of America
BAC
$436B
$31.5M 0.95%
2,047,962
+150,150
+8% +$2.33M
PM icon
23
Philip Morris
PM
$299B
$30.7M 0.93%
364,231
+4,650
+1% +$400K
MDT icon
24
Medtronic
MDT
$117B
$27.8M 0.84%
436,670
-146,140
-25% -$8.88M
COP icon
25
ConocoPhillips
COP
$157B
$27.4M 0.83%
319,931
+112,250
+54% +$8.75M

Similar funds

Oakbrook Investments's Q2 2014 Portfolio in Review

As of Q2 2014, Oakbrook Investments held 681 positions worth $3.31B, up 4.3% from $3.17B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oakbrook Investments's Q2 2014 filing shows 89 new, 221 increased, 279 reduced and 84 closed positions. Its largest new stake was EMC CORPORATION: 546,950 shares worth $14.4M. The largest sale was Oracle, an estimated $29.7M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

  • Oakbrook Investments's largest Q2 2014 buy was EMC CORPORATION: 546,950 shares worth $14.4M.
  • Oakbrook Investments added most to Verizon in Q2 2014, an estimated $34.1M increase.
  • Oakbrook Investments's biggest Q2 2014 reduction was Oracle, cutting an estimated $29.7M.
  • Oakbrook Investments fully exited Costco in Q2 2014, selling an estimated $14.4M.
  • Oakbrook Investments's ten largest holdings make up 19% of its $3.31B portfolio in Q2 2014.
  • Oakbrook Investments opened 89 new positions and closed 84 in Q2 2014.
  • Oakbrook Investments's portfolio value rose 4.3% quarter-over-quarter to $3.31B.

Based on Oakbrook Investments's 13F filing for Q2 2014, filed 17 Jul 2014.